Заболевания почек: бремя болезни и доступность медицинской помощи* - Журнал Терапевтический архив №6 Вопросы нефрологии 2019

Заболевания почек: бремя болезни и доступность медицинской помощи*

Крю Д., Белло А., Саади Г. Заболевания почек: бремя болезни и доступность медицинской помощи. Терапевтический архив. 2019; 91 (6):34–39. DOI: 10.26442/00403660.2019.06.000251

________________________________________________

Crews C.D., Bello A.K., Saadi G. Burden, access, and disparities in kidney disease. Therapeutic Archive. 2019; 91 (6): 34–39. DOI: 10.26442/00403660.2019.06.000251

Читать PDF

Аннотация

Заболевания почек – глобальная проблема общественного здравоохранения, затрагивающая более 750 млн человек во всем мире Распространенность заболеваний почек, а также их диагностика и лечение в разных странах существенно различаются. Значение и последствия заболеваний почек наиболее хорошо изучены в развитых странах, но в последнее время появляется все больше данных, свидетельствующих об аналогичной и даже более высокой распространенности заболеваний почек и в развивающихся странах. Во многих ситуациях частота заболеваний почек и обеспечение медицинской помощью определяются социально-экономическими, культурными и политическими факторами, что даже в развитых странах приводит к существенным различиям наносимого болезнью ущерба. Эти различия наблюдаются на разных этапах оказания помощи при заболеваниях болезнях почек: от профилактических мероприятий, направленных на предотвращение развития острого повреждения почек и хронической болезни почек, до скрининга на наличие болезни почек у лиц с высоким риском заболевания и доступа к специализированной медицинской помощи и проведению заместительной почечной терапии для лечения почечной недостаточности. Всемирный день почки – 2019 дает возможность повысить осведомленность о заболеваниях почек, а также осветить несоответствия между причиняемым ими ущербом и потенциальными возможностями их профилактики и лечения. В публикуемой передовой статье мы хотим заострить внимание на этих несоответствиях и подчеркиваем роль общественной политики и организационных структур в их устранении. Мы намечаем пути улучшения понимания этих различий, определяем основные подходы к достижению этого понимания, а также возможности оптимизации усилий для обеспечения равенства в вопросах поддержания здоровья почек во всем мире.

Ключевые слова: острое повреждение почек, терминальная почечная недостаточность, охрана здоровья населения мира, социальные детерминанты здоровья.

________________________________________________

Kidney disease is a global public health problem that affects more than 750 million persons worldwide. The burden of kidney disease varies substantially across the world, as does its detection and treatment. Although the magnitude and impact of kidney disease is better defined in developed countries, emerging evidence suggests that developing countries have a similar or even greater kidney disease burden. In many settings, rates of kidney disease and the provision of its care are defined by socioeconomic, cultural, and political factors, leading to significant disparities in disease burden, even in developed countries. These disparities exist across the spectrum of kidney disease – from preventive efforts to curb development of acute kidney injury or chronic kidney disease, to screening for kidney disease among persons at high risk, to access to subspecialty care and treatment of kidney failure with renal replacement therapy. World Kidney Day 2019 offers an opportunity to raise awareness of kidney disease and highlight disparities in its burden and current state of global capacity for prevention and management. In this editorial, we highlight these disparities and emphasize the role of public policies and organizational structures in addressing them. We outline opportunities to improve our understanding of disparities in kidney disease, the best ways for them to be addressed, and how to streamline efforts toward achieving kidney health equity across the globe.

Keywords: acute kidney injury, end stage renal disease, global health, health equity, social determinants of health.

Список литературы

1. Bello AK, Levin A, Tonelli M, et al. Global Kidney Health Atlas: a report by the International Society of Nephrology on the current state of organization and structures for kidney care across the globe. Available from: https://www.theisn.org/images/ISN_advocacy/GKHAtlas_ Linked_Compressed1.pdf. Published 2017. Accessed August 22, 2018.
2. Stanifer JW, Jing B, Tolan S, et al. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(3):174-81. doi: 10.1016/S2214-109X(14)70002-6
3. Davids MR, Eastwood JB, Selwood NH, et al. A renal registry for Africa: first steps. Clin Kidney J. 2016;9(1):162-7. doi: 10.1093/ckj/sfv122
4. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459-544. doi: 10.1016/S0140-6736(16)31012-1
5. Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975-82. doi: 10.1016/S0140-6736(14)61601-9
6. Mehta RL, Cerda J, Burdmann EA, et al. International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet. 2015;385(9987):2616-43. doi: 10.1016/S0140-6736(15)60126-X
7. Samuel SM, Palacios-Derflingher L, Tonelli M, et al. Association between First Nations ethnicity and progression to kidney failure by presence and severity of albuminuria. CMAJ. 2014;186(2):86-94. doi: 10.1503/cmaj.130776
8. Nicholas SB, Kalantar-Zadeh K, Norris KC. Racial disparities in kidney disease outcomes. Semin Nephrol. 2013;33(5):409-15. doi: 10.1016/j.semnephrol.2013.07.002
9. Van den Beukel TO, de Goeij MC, Dekker FW, et al. Differences in progression to ESRD between black and white patients receiving predialysis care in a universal health care system. Clin J Am Soc Nephrol. 2013;8(9):1540-7. doi: 10.2215/CJN.10761012
10. Crews DC, Gutierrez OM, Fedewa SA, et al. Low income, community poverty and risk of end stage renal disease. BMC Nephrol. 2014;15:192. doi: 10.1186/1471-2369-15-192
11. Garrity BH, Kramer H, Vellanki K, et al. Time trends in the association of ESRD incidence with area-level poverty in the US population. Hemodial Int. 2016;20(1):78-83. doi: 10.1111/hdi.12325
12. Parsa A, Kao WH, Xie D, et al. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med. 2013;369(23):2183-96. doi: 10.1056/NEJMoa1310345
13. Peralta CA, Bibbins-Domingo K, Vittinghoff E, et al. APOL1 genotype and race differences in incident albuminuria and renal function decline. J Am Soc Nephrol. 2016;27(3):887-93. doi: 10.1681/ASN.2015020124
14. Garcia-Garcia G, Agodoa LY, Norris KC, eds. Chronic Kidney Disease in Disadvantaged Populations. Cambridge, MA: Academic Press, 2017. P. 221-8.
15. Levin A, Stevens PE, Bilous RW, et al. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1-150.
16. Chan JC, Gregg EW, Sargent J, Horton R. Reducing global diabetes burden by implementing solutions and identifying gaps: a Lancet Commission. Lancet. 2016;387(10027):1494-5. doi: 10.1016/S0140-6736(16)30165-9
17. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217-23. doi: 10.1016/S0140-6736(05)17741-1
18. Plantinga LC, Miller ER 3rd, Stevens LA, et al. Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999–2006. Hypertension. 2009;54(1):47-56. doi: 10.1161/HYPERTENSIONAHA.109.12984
19. Banerjee T, Liu Y, Crews DC. Dietary patterns and CKD progression. Blood Purif. 2016;41(1-3):117-22. doi: 10.1159/000441072
20. Johnson AE, Boulware LE, Anderson CA, et al. Perceived barriers and facilitators of using dietary modification for CKD prevention among African Americans of low socioeconomic status: a qualitative study. BMC Nephrol. 2014;15:194. doi: 10.1186/1471-2369-15-194
21. Crews DC, Kuczmarski MF, Miller ER 3rd, et al. Dietary habits, poverty, and chronic kidney disease in an urban population. J Ren Nutr. 2015;25(2):103-10. doi: 10.1053/j.jrn.2014.07.008
22. Suarez JJ, Isakova T, Anderson CA, et al. Food access, chronic kidney disease, and hypertension in the U.S. Am J Prev Med. 2015;49(6):912-20. doi: 10.1016/j.amepre.2015.07.017
23. Crews DC, Kuczmarski MF, Grubbs V, et al. Effect of food insecurity on chronic kidney disease in lower-income Americans. Am J Nephrol. 2014;39(1):27-35. doi: 10.1159/000357595
24. Banerjee T, Crews DC, Wesson DE, et al. Food insecurity, CKD, and subsequent ESRD in US adults. Am J Kidney Dis. 2017;70(1):38-47. doi: 10.1053/j.ajkd.2016.10.035
25. Piccoli GB, Alrukhaimi M, Liu ZH, et al. Women and kidney disease: reflections on World Kidney Day 2018. Kidney Int. 2018;93(2):278-83. doi: 10.1016/j.kint.2017.11.008
26. Food and Agriculture Organization of the United Nations. The FAO hunger map 2015. Available from: http://www.fao.org/3/a-i4674e.pdf. Published 2015. Accessed August 22, 2018.
27. Shariff ZM, Khor GL. Obesity and household food insecurity: evidence from a sample of rural households in Malaysia. Eur J Clin Nutr. 2005;59(9):1049-58. doi: 10.1038/sj.ejcn.1602210
28. Popkin BM. Contemporary nutritional transition: determinants of diet and its impact on body composition. Proc Nutr Soc. 2011;70(1):82-91. doi: 10.1017/S0029665110003903
29. Sawhney S, Marks A, Fluck N, et al. Intermediate and long-term outcomes of survivors of acute kidney injury episodes: a large population-based cohort study. Am J Kidney Dis. 2017;69(1):18-28. doi: 10.1053/j.ajkd.2016.05.018
30. Heung M, Steffick DE, Zivin K, et al. Acute kidney injury recovery pattern and subsequent risk of CKD: an analysis of Veterans Health Administration data. Am J Kidney Dis. 2016;67(5):742-52. doi: 10.1053/j.ajkd.2015.10.019
31. Grams ME, Matsushita K, Sang Y, et al. Explaining the racial difference in AKI incidence. J Am Soc Nephrol. 2014;25(8):1834-41. doi: 10.1681/ASN.2013080867
32. Luyckx VA, Tuttle KR, Garcia-Garcia G, et al. Reducing major risk factors for chronic kidney disease. Kidney Int Suppl. 2017;7(2):71-87. doi: 10.1016/j.kisu.2017.07.003
33. Lewington AJ, Cerda J, Mehta RL. Raising awareness of acute kidney injury: a global perspective of a silent killer. Kidney Int. 2013;84(3):457-67. doi: 10.1038/ki.2013.153
34. Cervantes L, Tuot D, Raghavan R, et al. Association of emergency-only vs standard hemodialysis with mortality and health care use among undocumented immigrants with end-stage renal disease. JAMA Intern Med. 2018;178(2):188-95. doi: 10.1001/jamainternmed.2017.7039
35. Rizvi SA, Naqvi SA, Zafar MN, Akhtar SF. A kidney transplantation model in a low-resource country: an experience from Pakistan. Kidney Int Suppl. 2013;3:236-40. doi: 10.1038/kisup.2013.22
36. Roberti J, Cummings A, Myall M, et al. Work of being an adult patient with chronic kidney disease: a systematic review of qualitative studies. BMJ Open. 2018;8:e023507. doi: 10.1136/bmjopen-2018-023507
37. Kierans C, Padilla-Altamira C, Garcia-Garcia G, et al. When health systems are barriers to health care: challenges faced by uninsured Mexican kidney patients. PLoS One. 2013;8(1):e54380. doi: 10.1371/journal.pone.0054380
38. Murray CJ, Frenk J. A framework for assessing the performance of health systems. Bull World Health Organ. 2000;78(6):717-31.
39. Htay H, Alrukhaimi M, Ashuntantang GE, et al. Global access of patients with kidney disease to health technologies and medications: findings from the Global Kidney Health Atlas project. Kidney Int Suppl. 2018;8(2):64-73. doi: 10.1016/j.kisu.2017.10.010
40. Osman MA, Alrukhaimi M, Ashuntantang GE, et al. Global nephrology workforce: gaps and opportunities toward a sustainable kidney care system. Kidney Int Suppl. 2018;8(2):52-63. doi: 10.1016/j.kisu.2017.10.009
41. World Health Organization. Global Health Observatory indicator views. Available from: http://apps.who.int/gho/data/node.imr#ndx-P. Accessed August 22, 2018.
42. Harris DC, Dupuis S, Couser WG, Feehally J. Training nephrologists from developing countries: does it have a positive impact? Kidney Int Suppl. 2012;2(3):275-8. doi: 10.1038/kisup.2012.32
43. Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258-70. doi: 10.1038/ki.2011.368
44. Chionh CY, Soni SS, Finkelstein FO, et al. Use of peritoneal dialysis in AKI: a systematic review. Clin J Am Soc Nephrol. 2013;8(10):1649-60. doi: 10.2215/CJN.01540213
45. Muralidharan A, White S. The need for kidney transplantation in low- and middle-income countries in 2012: an epidemiological perspective. Transplantation. 2015;99(3):476-78. doi: 10.1097/TP.0000000000000657

________________________________________________

Авторы

Д. Крю1-3, А. Белло4, Г. Саади5; для Организационного комитета Всемирного дня почки6

1 Отдел нефрологии, медицинский факультет, Медицинская школа Университета Джонса Хопкинса, Балтимор, Мэриленд, США;
2 Научно-исследовательский центр Уэлч по профилактике, эпидемиологии и клиническим исследованиям, Медицинский институт Университета Джонса Хопкинса, Балтимор, Мэриленд, США;
3 Центр Джонса Хопкинса по обеспечению равенства в вопросах здравоохранения, Медицинский институт Университета Джонса Хопкинса, Балтимор, Мэриленд, США;
4 Отдел нефрологии и трансплантационной иммунологии, медицинский факультет, Альбертский университет, Эдмонтон, Канада;
5 Отделение нефрологии, отдел внутренних болезней, медицинский факультет, Каирский университет, Гиза, Египет;
6 cписок членов Организационного комитета Всемирного дня почки см. в Приложении

________________________________________________

Deidra C. Crews1-3, Aminu K. Bello4, Gamal Saadi5; for the World Kidney Day Steering Committee6

1 Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA;
2 Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA;
3 Johns Hopkins Center for Health Equity, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA;
4 Division of Nephrology & Transplant Immunology, Department of Medicine, University of Alberta, Edmonton, Canada;
5 Nephrology Unit, Department of Internal Medicine, Faculty of Medicine, Cairo University, Giza, Egypt;
6 See Appendix for list of members of the World Kidney Day Steering Committee

Назад к списку

Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.